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Received May 31, 2011; accepted September 16, 2011AbstractMethylmalonic acidemia (MMA) is a very rare genetic disease of metabolism that progressively leads to neurological and renal sequelae.
This report describes an unusual case of a patient with MMAwho developed severe hyperkalemia and severe dysrhythmia during anesthesia. A
13-month-old male infant with MMA underwent urgent insertion of a port-a-cath under general anesthesia. A life-threatening arrhythmia
suddenly occurred, with severe hyperkalemia (up to 7.4 mmol/L), immediately following induction of anesthesia. Emergent resuscitation was
successfully carried out, with a complete neurological recovery after 7 days after surgery. Although MMA is a rare complication, the possibility
of severe hyperkalemia should be considered in the differential diagnosis of patients with MMA presenting with wide QRS complex tachycardia.
The management and intraoperative complications of this disorder are reported here, and the available literature is reviewed.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Methylmalonic acidemia (MMA) is an autosomal recessive
error of metabolism of methylmalonyl coenzyme A that
occurs in about 1 per 100,000 newborns in Taiwan.1 Most
cases of MMA are caused by a deficiency of methylmalonyl-
CoA mutase, with patients developing progressive neurolog-
ical and renal sequelae.2 Hyperkalemia (serum Kþ level
>5.5 mmol/L) after acute metabolic decompensation some-
times appears even in the phase of normal renal function.3
However, rare reports have been published on anesthesia and
intraoperative complications associated with this disorder.
Here, we describe a case of a male infant with MMA who* Corresponding author. Dr. Cheng-Ming Tsao, Department of Anesthesiology,
Taipei Veterans General Hospital, 201, Section 2, Shipai Road, Taipei 112,
Taiwan, ROC.
E-mail address: cmtsao@vghtpe.gov.tw (C.-M. Tsao).
1726-4901/$ - see front matter Copyright  2012 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2012.03.004suffered from sudden severe hyperkalemia and ventricular
arrhythmia just after induction of anesthesia.
2. Case report
A 13-month-old boy, 12 kg in weight, with MMA was
admitted because of progressive jaundice lasting for more than
a week. The diagnosis of MMA was made after a series of
newborn screening tests. The boy underwent a living donor
liver transplantation (LDLT) in our hospital when he was 8
months old. After the transplantation, he took tacrolimus,
lamivudine, and carnitene supplements for further treatment,
and analysis showed amino acid levels within the normal
range. Although his renal function was normal, persistent
hyperkalemia (about 5.9e6.5 mmol/L) was noted during
follow-up.
Anastomotic stricture of the biliary duct was suspected after
admission, and percutaneous transhepatic biliary drainagehinese Medical Association. All rights reserved.
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thesia to relieve blockages in the bile duct. Unfortunately, the
patient developed a postoperative fever and poor appetite with
vomiting occurred for the first three days after PTBD, and
a peripheral intravenous line could not easily be set up.
Therefore, urgent port-a-cath implantation was suggested for
long-term parenteral nutrition and fluid supply. Preoperative
laboratory investigations showed serum levels of creatinine
94.6 mmol/L, urea nitrogen 23.2 mmol/L, Kþ 5.8 mmol/L, Naþ
135 mmol/L, and C-reactive protein 489 nmol/L.
Upon the patient’s arrival in the operating room, electro-
cardiography (ECG), pulse oximetry, and automatic nonin-
vasive blood pressure (BP) readings were monitored
continuously. A preoperative ECG showed sinus tachycardia
with peaked T-waves (Fig. 1A), the BP was 85/42 mmHg, and
pulse oximetry gave a value of 100% saturation. We initially
set up a peripheral intravenous line over the patient’s frontal
area under inhalation anesthesia of sevoflurane and nitrous
oxide with an FiO2 of 0.4. Atropine 0.1 mg and cisatracurium
3 mg were then added to facilitate intubation with an uncuffed
endotracheal tube. General anesthesia was maintained with
sevoflurane 1.5e2.0% and nitrous oxide 60% in oxygen, with
positive-pressure ventilation to keep the end-tidal carbon
dioxide concentration at 30e35 mmHg.
About 5 minutes after intubation, wide QRS complex
ventricular tachycardia (VT) suddenly appeared, with signifi-
cant hemodynamic changes (Fig. 1B). The patient’s BP couldFig. 1. Electrocardiograph changes: (A) normal sinus rhythm with peaked
T-wave at 131 beats/min (bpm); (B) wide QRS complex ventricular tachy-
cardia at 146 bpm; (C) pulseless electricity activity; (D) wide QRS complex
ventricular tachycardia at 130 bpm; (E) sinus tachycardia at 208 bpm.not be measured using the pressure cuff. Two 10 mg doses of
lidocaine were given, but the heart rhythm soon changed to
low-voltage electrical activity (Fig. 1C). Meanwhile, emergent
resuscitation was performed using cardiac massage and
epinephrine. We then immediately set up an intra-arterial
catheter in the radial artery, with an arterial BP reading of
around 46/27 mmHg. The arterial blood gases showed pH
7.37, PaO2 450.7 mmHg, PaCO2 27.3 mmHg, base excess
e9.5 mmol/L, and serum Kþ 6.9 mmol/L.
Severe hyperkalemia and metabolic acidosis with respira-
tory compensation were diagnosed. Therefore, calcium chlo-
ride, insulin, sodium bicarbonate, and furosemide were
administered to treat the hyperkalemia. About 5 minutes later,
wide QRS complex VT resumed at a rate of 233 beats per
minute (bpm; Fig. 1D), and the serum Kþ level was recorded
as 7.4 mmol/L. The frequency of VT progressively decreased,
the ECG showed sinus tachycardia (Fig. 1E), and the serum
Kþ level decreased to 5.7 mmol/L. The systolic BP recovered
to around 80 mmHg. During this episode, the patient’s oxygen
saturation remained stable at 94e100%. However, levels of
serum creatinine of 196.2 mmol/L and urea nitrogen of 42.8
mmol/L were found. Thereafter, the port-a-cath implantation
went smoothly under general anesthesia.
After the operation, the boy was transferred to the pediatric
intensive care unit for further evaluation and medical treat-
ment. His recovery was uneventful and his ECG normal. No
cardiovascular or neurological complications developed, and
he was discharged. He continued to do well during the 6
months of follow-up.
3. Discussion
In considering what led to such extreme potassium shifts
in our patient, the potential causes might be divided into
two types: chronic and acute. Chronic hyperkalemia usually
develops with ineffective potassium excretion, resulting from
renal insufficiency, a defect in tubular secretion, and/or
medications. In this case, the patient’s serum creatinine level
was within normal limits before the operation, suggesting that
there was no significant renal insufficiency. Some case studies
have also shown persistent hyperkalemia in children with
MMA, even though their creatinine clearance was low.4,5 Pela
et al reported two patients with MMAwith normal glomerular
filtration who displayed hyperkalemia and metabolic acidosis;
type IV renal tubular acidosis was diagnosed.3 Therefore, it is
supposed that hyperkalemia can be caused by acute metabolic
decompensation even in the phase of normal renal function.
In addition, it is known that tacrolimus, an immunosup-
pressant, may lead to calcineurin inhibitor nephrotoxicity and
renal tubular acidosis via unknown mechanisms.6,7 This infant
received tacrolimus after LDLT to attenuate the risk of organ
rejection. Therefore, it is likely that the tacrolimus might have
aggravated the complications of hyperkalemia and metabolic
crisis in our case.
The acceptable value for serum Kþ prior to surgery in order
to avoid the life-threatening risk of hyperkalemia has been
reported to be 6.0e6.2 mmol/L,8 although one newborn with
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sequelae under general anesthesia.9 Potential causes of peri-
operative hyperkalemia might be attributed to an excessive
potassium load and transmembrane potassium ion redistribu-
tion caused by acidosis and drugs.10 Our patient did not
receive a massive blood transfusion, potassium supplements,
succinylcholine, or beta-blockers, all of which may elevate
serum Kþ levels.
However, children with MMA are at increased risk for
metabolic decompensation, particularly with infections,
trauma, surgery, anesthesia, and psychosocial stress. There-
fore, acidosis, hyperglycemia, and increased levels of stress
hormones may develop after induction of anesthesia, and
serum Kþ concentration then becomes transiently elevated. In
addition, a rapid deterioration in renal function caused by
inadequate fluid intake before operation might have further
aggravated the elevation in serum Kþ concentration in our
case. Thus, it is better to keep within the normal limits of
potassium level before induction of anesthesia, especially in
patients with MMA.
Progressive changes in the ECG manifest as serum Kþ level
increases: a peaked T wave, prolonged PR interval, widened
QRS complexes, ventricular fibrillation, and asystole.10 To
treat wide QRS VT with a pulse, synchronized electrical car-
dioversion and/or antiarrhythmic drugs are immediately used
if hemodynamic conditions are unstable, but defibrillation
should be used if there is no pulse.11 Lidocaine is a class Ib
antiarrhythmic that decreases ectopic firing points in the heart
to suppress sustained ventricular arrhythmia. However,
McLean et al reported that lidocaine precipitated a profound
conduction disturbance and asystole in two patients with
hyperkalemia.12 Hyperkalemia-induced resting membrane
depolarization can inactivate sodium channels and then
markedly increase lidocaine binding, potentiating its effects on
blocking conduction.13 Thus, it is probable that the patient’s
rhythm degenerated to low-voltage electric activity due to
lidocaine use.
There is some evidence to suggest a reduced efficacy of
antiarrhythmic therapy in the presence of severe hyper-
kalemia.14,15 Therefore, in the presence of severe hyper-
kalemia in anesthesia, the serum Kþ concentration must be
directly reduced using calcium to stabilize the myocardial
membrane, sodium bicarbonate and glucose plus insulin given
to shift Kþ into the cells, and furosemide administered to
effectively promote potassium excretion, rather than following
the treatment algorithms for wide QRS complex VT.16In conclusion, patients with MMA are potentially at risk
for perioperative hyperkalemia caused by acute metabolic
acidosis and renal insufficiency. Although this is a rare
complication, the possibility of severe hyperkalemia should be
considered in the differential diagnosis of patients with MMA
presenting with wide QRS complex tachycardia.
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